Categories: NewsSports medicine

OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WARSAW, Ind., April 17, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2023 financial results on Monday, May 1, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 2, 2023, at 8:00 a.m. ET to discuss the results.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 47 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact:
Philip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

Staff

Recent Posts

Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution

SINGAPORE, Oct. 8, 2025 /PRNewswire/ -- Neopharma Technologies Ltd ("Neopharma"), a digital health company pioneering…

1 hour ago

CERTIFY Health Releases New Insights Brief Revealing How Practices Achieve 400-600% ROI by Automating From the Point of Check-In

Data from 700+ healthcare leaders and 1,000+ practices shows measurable gains in revenue recovery, staff…

1 hour ago

EMA Wellness Bolsters Executive Leadership to Scale its Market Leading Clinical Trial Platform

New CMO, EVP Operations and SVP Clinical Solutions bring track records of scalable growth and…

1 hour ago

AYUMETRIX Launches Nova: Smart AI Companion for Wellness and Diagnostics

LAKE OSWEGO, Ore., Oct. 8, 2025 /PRNewswire/ -- AYUMETRIX, an early innovator for modern, at-home…

1 hour ago

eschbach Awarded Two Honors in the 2025 Pharmaceutical Technology Excellence Awards for Innovations in Pharmaceutical Manufacturing

BOSTON, Oct. 8, 2025 /PRNewswire/ -- eschbach, developer of Shiftconnector®, an intelligent operations platform for…

1 hour ago

WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $478,000

JERSEY CITY, N.J., Oct. 8, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of…

7 hours ago